Bruker (BRKR) Receives a Hold from Needham

By Carrie Williams

In a report released today, Stephen Unger from Needham maintained a Hold rating on Bruker (BRKRResearch Report). The company’s shares closed last Tuesday at $37.95.

According to, Unger is a 5-star analyst with an average return of 14.3% and a 70.5% success rate. Unger covers the Healthcare sector, focusing on stocks such as Myriad Genetics, Thermo Fisher, and PerkinElmer.

Currently, the analyst consensus on Bruker is a Hold with an average price target of $41.44, a 6.1% upside from current levels. In a report issued on May 1, Cleveland Research also downgraded the stock to Hold with a price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $54.49 and a one-year low of $30.78. Currently, Bruker has an average volume of 984.6K.

Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of BRKR in relation to earlier this year. Most recently, in March 2020, Frank Laukien, the CEO & President of BRKR bought 25,000 shares for a total of $610,000.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.